The data provided on this page is updated by the organisations.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.
General | |
---|---|
The information has been reviewed in year : | |
Organisation name: | Ezer Mizion Bone Marrow Donor Registry |
Organisation ION: | ION-4987 |
Country: | Israel |
Year the registry started operations: | 1998 |
Products | comment | |
---|---|---|
Do you provide HPC, Marrow? | yes | |
Do you provide HPC, Apheresis? | yes | |
Do you provide HPC, Cord Blood? | no | |
Do you provide MNC, Apheresis? | yes | |
Do you provide NC, Whole Blood? | yes |
Product quantity | ||
---|---|---|
Data valid for year | 2018 | |
Number of products | National | International |
HPC, Marrow products: | 10 | 16 |
HPC, Apheresis: | 112 | 204 |
HPC, Cord: | N/A | N/A |
License | |
---|---|
Organisation is licensed/accredited by the Competent Authority: | yes |
Comment: | Israeli Ministry of Health |
Name of Competent Authority: | |
Date of last inspection: | 09/08/2017 |
Link to website of Competent Authority: | http://www.health.gov.il/English/Pages/HomePage.aspx |
Can you provide the Legal documentation from the Competent Authority that your organisation is allowed to operate as a registry ? | yes |
Is your registry WMDA Certified, WMDA Qualified or WMDA Accredited? | WMDA Accredited |
The registry is accredited by any other organisation: | yes |
If yes, by which organisation? | ISO27001:2013 And ISO27799:2008 |
Affiliation | |
---|---|
The registry works with the following number of affiliated donor centres: | None. The registry operates as registry and donor center |
The registry audits its donor centres: | N/A |
The registry works with the following numer of affiliated collection centres: | 2 |
Ther registry audits its collection centres: | Paper audit every year and visit audit every 3 years if JACIE accreditation is not available. |
The registry works with the following number of affiliated Cord Blood Banks: | 0 |
The registry audits its Cord Blood Banks: | N/A |
The registry works with the following number of affiliated transplant centres: | 6 |
The registry audits its transplant centres: | Every year (paper audit) |
The registry works with the following number of affiliated IDM Testing Laboratories: | 2 |
The registry audits its IDM Testing Laboratories: | Every year (paper audit) |
The registry works with the following number of affiliated HLA/other DNA markers testing laboratories: | 1 |
The registry audits its HLA/other DNA markers testing laboratories: | Every year (paper audit) |
The registry would be able to provide a full list of name/addresses of each affiliated and their licence/accreditation status, on request: | yes |
The Cord Blood Banks are FACT-NetCord accredited: | |
If yes, the following Cord Blood Bank(s) are accredited: | |
The registry is able to provide a copy of all the certificates: | yes |
Affiliated centres comply with WMDA Standards and applicable national regulations: | yes |
The registry has requirements for affiliated centres in addition to WMDA Standards and applicable national regulations: | no |
If yes, what are these requirements? |
Donor policy | |
---|---|
All donors are unpaid volunteers: | yes |
All donors are informed about donation process and associated risks: | yes |
Donors sign a valid informed consent to donate in the presence of a medical doctor/health care personnel/registry staff: | yes |
The registry has systems in place to protect and control access to donor/patient records: | yes |
The registry maintains donor anonymity: | yes |
The registry has detailed donor evaluation and exclusion criteria in place: | yes |
The registry has donor evaluation and exclusion criteria that do meet or exceed the WMDA guidelines: | yes |
IDM
IDM | Tested | Method | Days between test and sampling/workup |
---|---|---|---|
ALT/ASTALT/AST ratio, De-Ritis-Quotient | Yes | before stem cell donation date | |
ChagasChagas, T. cruzi | No | ||
CMV IgGCytomegalovirus (CMV) Antibody testing IgG | Yes | CMIA (by Abbot) | before stem cell donation date |
CMV IgMCytomegalovirus (CMV) Antibody testing IgM | Yes | CMIA (by Abbot) | before stem cell donation date |
CMV TotalCytomegalovirus Total | No | ||
EBV IgGEpstein-Barr Virus Antibody testing IgG | Yes | CMIA (by Abbot) - Only if EBNA IgG is Neg | before stem cell donation date |
EBV IgMEpstein-Barr Virus Antibody testing IgM | Yes | CMIA (by Abbot) - Only if EBNA IgG is Neg | before stem cell donation date |
HAV (NAT)Anti-hepatitis A virus nucleic acid testing | On request | ||
HBV (NAT)Hepatitis B nucleic acid testing | Yes | NAT Ultrio Elite, PANTHER by Procleix | before stem cell donation date |
HBc AbHepatitis B core antibody testing | Yes | CMIA (by Abbot) | before stem cell donation date |
HBs AgHepatitis B Surface antigen testing | Yes | CMIA (by Abbot) | before stem cell donation date |
HCV (NAT)Hepatitis C nucleic acid testing | Yes | NAT Ultrio Elite, PANTHER by Procleix | before stem cell donation date |
HCV AbHepatitis C antibody testing | Yes | CMIA (by Abbot) | before stem cell donation date |
HEV (NAT)Hepatitis E Virus nucleic acid testing | On request | ||
HIV (NAT)Human Immunodeficiency Virus nucleic acid testing | Yes | NAT Ultrio Elite, PANTHER by Procleix | before stem cell donation date |
HIV-1 AbHuman Immunodeficiency Virus HIV-1 antibody testing | Yes | Combo, CMIA (by Abbot) | before stem cell donation date |
HIV-2 AbHuman Immunodeficiency Virus HIV-2 antibody testing | Yes | before stem cell donation date | |
HIV p24Human Immunodeficiency Virus p24 antigen testing | Yes | before stem cell donation date | |
HTLV-IHuman T-Lymphotropic Virus type I testing | Yes | rHTLV-I/II CMIA (by Abbot) | before stem cell donation date |
HTLV-IIHuman T-Lymphotropic Virus type II testing | Yes | rHTLV-I/II CMIA (by Abbot) | before stem cell donation date |
MalariaMalaria | On request | ||
HSVHerpes Simplex Virus | On request | ||
STSSerological tests for syphilis | Yes | TP-HA by CMIA; RPR only if TP-HA pos | before stem cell donation date |
STS FTA-ABSSerological test for syphilis | - | ||
ToxoplasmosisToxoplasmosis | Yes | CMIA (by Abbot) | before stem cell donation date |
VZVVaricella Zoster Virus | On request | ||
WNV-NATWest Nile Virus nucleic acid testing | Yes | Aptima Combo 2, PANTHER (Gen-Probe) | before stem cell donation date |
Other tests performed | - |
Testing | |
---|---|
The physical and medical exam at donor workup is performed by a medical doctor: | yes |
All donor testing (at workup) for infectious disease is performed in a laboratory certified/licensed by a Competent Authority: | yes |
HLA typing for patient specific request is performed in an appropriately accredited laboratory: | yes |
Sterility testing is performed on the adult donor product: | yes |
Sterility testing is performed on the cord blood product: | |
Screening questionnaire to exclude communicable disease: | yes |
Screening questionnaire to exclude donors with 'high risk' lifestyles: | yes |
Donor reliability identified by a medical doctor: | yes |
Donor clearance to donate is confirmed by a medical doctor, following as a minimum the donor exclusion criteria in Annex 1 of EU Directive 2006/17/EC : | yes |
Customs regulations | |
---|---|
Are there any customs regulations to follow, or customs paperwork required, to import cell products into the organisation country? If yes, please specify: | |
Are there any customs regulations to follow, or customs paperwork required, to export cell products from the organisation country? If yes, please specify: | |
Are there any import regulations to follow, or paperwork required, to import cell products into the organisation country? If yes, please specify: | |
Are there any export regulations to follow, or paperwork required, to export cell products from the organisation country? If yes, please specify: |
Reporting of Serious Adverse Events | |
---|---|
Please indicate which of the following schemes for reporting Serious Adverse Events relating to either the Donor or the product the Registry participates in: | |
- Mandatory National Reporting Scheme | yes |
- Voluntary National Reporting Scheme | yes |
- WMDA SEAR/SPEAR Reporting Scheme | yes |
The registry will notify the receiving Registry within 24 hours of receiving information relating to any serious adverse event that could be considered to affect the patient receiving the product: | yes |
Quality management | |
---|---|
The registry does maintain Standard Operating Procedures for your work: | yes |
The registry would be willing to provide these to WMDA or another registry upon request: | yes |
The registry would be willing to provide WMDA or another registry, on request, with copies of any packaging the HPC product will arrive in: | yes |
Donor records relating to the medical exam and HPC collection process are the following number(s) of year(s) retained: | Unlimited |